Cvs Topical Analgesic Hemorrhoidal Ointment
NDC Package 51316-207-28

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Cvs Topical Analgesic Hemorrhoidal (dibucaine) ointment is adults and children 12 years and over: if possible, clean the affected area with mild soap and warm water and rinse thoroughly. This formulation utilizes a ointment delivery system. Marketed by Cvs Pharmacy,inc, this product is identified by NDC 51316-207 and is authorized under FDA application M015.

Identification & Billing

NDC Package Code
51316-207-28
Package Description
28 mL in 1 TUBE
Product Code
51316-207
11-Digit Billing Format
51316020728
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Cvs Topical Analgesic Hemorrhoidal
Non-Proprietary Name
Dibucaine
Substance Name
Dibucaine
Dosage Form
Ointment - A semisolid3 dosage form, usually containing <20% water and volatiles5 and >50% hydrocarbons, waxes, or polyols as the vehicle. This dosage form is generally for external application to the skin or mucous membranes.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
DIBUCAINE 10 mg/mL
Pharmacologic Class
Usage Information
Adults and children 12 years and over: if possible, clean the affected area with mild soap and warm water and rinse thoroughly. Dry by patting or blotting with toilet tissue or a soft cloth before applying.apply externally to the affected area up to 3 or 4 times daily.children under 12 years of age: ask a doctor.

Regulatory & Marketing

Labeler Name
Cvs Pharmacy,inc
Product Type
Human Otc Drug
FDA Application #
M015
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
02-14-2026
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 51316-207-28 identifies a specific commercial package of 28 ml in 1 tube of Cvs Topical Analgesic Hemorrhoidal, a human over the counter drug labeled by Cvs Pharmacy,inc. This ointment is formulated for topical use and contains dibucaine as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Cvs Pharmacy,inc on February 14, 2026. The current certification is valid through December 31, 2027.

How is this Cvs Pharmacy,inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 51316020728. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
51316-207-28
11-Digit CMS (5-4-2)
51316-0207-28

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.